Investor Overview

Development Stage Company

Tissue Genesis has a limited operating history, and has not yet commercialized any products and therefore, has not generated product revenues. To date, the company has focused on development of its BOS platform products and the development of autologous adipose-derived cells for use in various applications, including wound care solutions and endothelialized grafts for vascular applications. The company has been profitable in its early R & D stages due to government contract revenues.

Capitalization

Please contact us for information regarding our capitalization activities..

For more investor information contact us at:

Tissue Genesis, Inc.
677 Ala Moana Boulevard
Suite 1100
Honolulu, HI 96813

Phone: (808) 539-9331
Fax: (808) 539-9345

Email Tissue Genesis, Inc.